primary localized cutaneous amyloidosis 3

Description

Primary Localized Cutaneous Amyloidosis (PLCA)

Primary localized cutaneous amyloidosis (PLCA) is a rare skin condition that causes an abnormal build-up of proteins called amyloids in the skin. The normal function of these proteins is disrupted, leading to the accumulation of amyloid deposits in the dermis, which is the layer of skin beneath the epidermis.

Characteristics

  • PLCA is characterized by the deposition of amyloid protein in the skin without systemic involvement.
  • It is a relatively rare chronic condition.
  • The amyloid deposits are typically found in the papillary dermis, which is the uppermost layer of the dermis.
  • Histopathology using Haematoxylin and Eosin (H&E) stain shows eosinophilic hyaline material in the papillary dermis.

Symptoms

  • The condition is often asymptomatic, but some people may experience pruritus (itching) or skin scratching.
  • In some cases, the amyloid deposits can cause localized skin lesions or nodules.

Variants

  • PLCA consists of three main variants: macular amyloidosis, lichen amyloidosis, and nodular localized cutaneous amyloidosis (NLCA).

References

  • [3] Primary localized cutaneous amyloidosis is defined by the deposition of amyloid protein in the skin without systemic involvement.
  • [10] Description. Primary localized cutaneous amyloidosis (PLCA) is a condition in which clumps of abnormal proteins called amyloids build up in the skin, specifically in the wave-like projections (dermal papillae) between the top two layers of skin (the dermis and the epidermis).
  • [12] Primary Localized Cutaneous Amyloidosis (PLCA) is a relatively rare chronic condition characterized by amyloid deposition in dermis without associated deposits in internal organs.

Additional Characteristics

  • Primary Localized Cutaneous Amyloidosis (PLCA) is a relatively rare chronic condition characterized by amyloid deposition in dermis without associated deposits in internal organs.
  • Primary localized cutaneous amyloidosis (PLCA) is a condition in which clumps of abnormal proteins called amyloids build up in the skin, specifically in the wave-like projections (dermal papillae) between the top two layers of skin (the dermis and the epidermis).

Signs and Symptoms

Macular Amyloidosis Signs and Symptoms

Macular amyloidosis, a type of primary localized cutaneous amyloidosis, is usually characterized by intense itching. The condition can manifest as clusters of small skin or dark-colored scaly bumps on the skin, which may merge together to form larger patches.

  • Itching: Macular amyloidosis is typically very itchy, making it uncomfortable for those affected.
  • Skin lesions: The condition appears as clusters of small skin or dark-colored scaly bumps, which can merge together to form larger patches.
  • Location: These skin lesions can occur on various parts of the body, including the trunk, limbs, face, and/or genitals.

According to [3], lichen amyloidosis is another type of primary localized cutaneous amyloidosis that presents with similar symptoms. However, it's essential to note that the exact underlying cause of primary cutaneous amyloidosis remains poorly understood [2].

Additional Symptoms

  • Skin lesions
  • Clusters of small skin or dark-colored scaly bumps
  • Larger patches on the skin
  • Skin lesions on various parts of the body
  • itching

Diagnostic Tests

Diagnostic Tests for Primary Localized Cutaneous Amyloidosis

Primary localized cutaneous amyloidosis (PLCA) can be challenging to diagnose, but various tests can help confirm the condition. Here are some diagnostic tests that may be used:

  • Laboratory studies: A complete blood cell count, serum chemistry profile, and liver function tests may be part of a general workup [3].
  • Imaging tests: Chest radiography, electrocardiography, abdominal ultrasonography, and scintigraphy with radioiodinated serum amyloid P component (SAP scanning) may also be used to rule out other conditions or monitor the progression of PLCA [3].

Additional Tests

Other tests that may be performed to aid in diagnosis include:

  • Pathological examination: A skin biopsy can help confirm the presence of amyloid deposits in the dermis.
  • Blood and urine tests: These may be used to detect abnormal proteins or other biomarkers associated with PLCA.

It's essential to note that a definitive diagnosis of PLCA often requires a combination of clinical evaluation, laboratory tests, and pathological examination. A healthcare professional can help determine the best course of action for diagnostic testing.

Additional Diagnostic Tests

  • Imaging tests
  • Blood and urine tests
  • Laboratory studies
  • Pathological examination

Treatment

Treatment Options for Primary Localized Cutaneous Amyloidosis (PLCA)

Primary localized cutaneous amyloidosis (PLCA) is a condition in which clumps of abnormal proteins called amyloids build up in the skin. While there are various treatment options available, the primary focus is on relieving aesthetic disfigurement and pruritus (itching).

General Measures

  • Moisturizer and emollient use: Keeping the affected area moisturized can help reduce itching and discomfort.
  • Avoidance of scratching: Scratching can further irritate the skin and make symptoms worse.

Specific Treatments

  • Topical therapies:
    • High-potency topical corticosteroids
    • Calcipotriene
    • Menthol (4)
  • Systemic therapies:
    • Acitretin
    • Cyclophosphamide

Note: The effectiveness of these treatments may vary from person to person, and a healthcare professional should be consulted for personalized advice.

References:

[9] Primary localized cutaneous amyloidosis (PLCA) is a condition in which clumps of abnormal proteins called amyloids build up in the skin. [3] Treatment focuses on relief of aesthetic disfigurement and pruritus. General measures. Moisturiser and emollient use; Avoidance of scratching. [6] Topical therapies for PLCA include high potency steroids, calcipotriene, and menthol (4). Systemic therapies include acitretin, cyclophosphamide and ...

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnoses for Primary Localized Cutaneous Amyloidosis

Primary localized cutaneous amyloidosis (PLCA) is a condition in which clumps of abnormal proteins called amyloids build up in the skin. When considering differential diagnoses, several conditions should be taken into account.

  • Acalculous Cholecystopathy: This is a rare condition characterized by inflammation of the gallbladder without any visible stones or other obstructions.
  • Colloid Milium: A benign condition that presents as small, yellowish or whitish papules on the skin, often on the face and neck.
  • Cutaneous Pseudolymphoma: A type of skin cancer that can mimic lymphoma in its appearance and behavior.
  • Leiomyoma: A rare tumor that arises from smooth muscle cells.

These conditions should be considered when differentiating primary localized cutaneous amyloidosis, as they may present with similar symptoms or characteristics. However, it's essential to note that each of these conditions has distinct features and requires a comprehensive diagnostic evaluation.

References:

  • [3] Jun 17, 2024 — Differential Diagnoses · Acalculous Cholecystopathy · Colloid Milium · Cutaneous Pseudolymphoma · Leiomyoma.
  • [5] Differential diagnosis of primary cutaneous amyloidosis​​ Primary cutaneous amyloidosis should be considered when faced with minimal pathological changes, aptly ...
  • [7] Aug 11, 2023 — Differential Diagnoses · AA (Inflammatory) Amyloidosis · Achalasia · Achlorhydria · Cutis Verticis Gyrata · Familial Renal Amyloidosis · Mastocytosis.

Additional Differential Diagnoses

  • Acalculous Cholecystopathy
  • Colloid Milium
  • Cutaneous Pseudolymphoma
  • leiomyoma

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0080932
core#notation
DOID:0080932
oboInOwl#hasDbXref
MIM:617920
oboInOwl#hasExactSynonym
Amyloidosis cutis dyschromica
rdf-schema#label
primary localized cutaneous amyloidosis 3
IAO_0000115
A primary cutaneous amyloidosis that is characterized by deposits of keratinocyte-derived amyloid in the skin and that has_material_basis_in homozygous or compound heterozygous mutation in the GPNMB gene on chromosome 7p15. Onset occurs before puberty and involves macular or reticulate hyperpigmentation admixed with symmetrically distributed guttate hypopigmented and hyperpigmented lesions.
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_0050639
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_3784
owl#annotatedSource
t357540

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.